Evidence map›Paper›PMID 38860844›Full record

ArticleEuropean journal of neurology2025

Scoping review of clinical decision support systems for multiple sclerosis management: Leveraging information technology and massive health data.

Stanislas Demuth, Chadia Ed-Driouch, Cédric Dumas, David Laplaud, Gilles Edan, Nicolas Vince, Jérôme De Sèze, Pierre-Antoine Gourraud

Abstract readScoping Review
In one paragraph

Article in European journal of neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Stanislas DemuthINSERM CIC 1434, Clinical Investigation Center, University Hospital of Strasbourg, Strasbourg, France.
Chadia Ed-DriouchINSERM, CR2TI-Center for Research in Transplantation and Translational Immunology, Nantes Université, Nantes, France.
Cédric DumasDépartement Automatique, Productique et Informatique, IMT Atlantique, CNRS, LS2N, UMR CNRS 6004, Nantes, France.
David LaplaudINSERM, CR2TI-Center for Research in Transplantation and Translational Immunology, Nantes Université, Nantes, France.
Gilles EdanDepartment of Neurology, University Hospital of Rennes, Rennes, France.
Nicolas VinceINSERM, CR2TI-Center for Research in Transplantation and Translational Immunology, Nantes Université, Nantes, France.
Jérôme De SèzeINSERM CIC 1434, Clinical Investigation Center, University Hospital of Strasbourg, Strasbourg, France.
Pierre-Antoine GourraudINSERM, CR2TI-Center for Research in Transplantation and Translational Immunology, Nantes Université, Nantes, France.

Funding

Agence Nationale de la Recherche ANR-17-RHUS-0010Agence Nationale de la Recherche ANR-21-RHUS-0014Conseil Régional des Pays de la Loire 2019_11235European Commission 754995European Union's Horizon 2020 Research and Innovation Programme 754995
6 · The paper itself

Abstract

background and purposeMultiple sclerosis (MS) is a complex autoimmune disease of the central nervous system, with numerous therapeutic options, but a lack of biomarkers to support a mechanistic approach to precision medicine. A computational approach to precision medicine could proceed from clinical decision support systems (CDSSs). They are digital tools aiming to empower physicians through the clinical applications of information technology and massive data. However, the process of their clinical development is still maturing; we aimed to review it in the field of MS.

methodsFor this scoping review, we screened systematically the PubMed database. We identified 24 articles reporting 14 CDSS projects and compared their technical and software development aspects.

resultsThe projects position themselves in various contexts of usage with various algorithmic approaches: expert systems, CDSSs based on similar patients' data visualization, and model-based CDSSs implementing mathematical predictive models. So far, no project has completed its clinical development up to certification for clinical use with global release. Some CDSSs have been replaced at subsequent project iterations. The most advanced projects did not necessarily report every step of clinical development in a dedicated article (proof of concept, offline validation, refined prototype, live clinical evaluation, comparative prospective evaluation). They seek different software distribution options to integrate into health care: internal usage, "peer-to-peer," and marketing distribution.

conclusionsThis review illustrates the potential of clinical applications of information technology and massive data to support MS management and helps clarify the roadmap for future projects as a multidisciplinary and multistep process.

Indexed as

Decision Support Systems, ClinicalMultiple SclerosisBig DataHumansInformation Technologyartificial intelligencebig dataclinical decision support systemmultiple sclerosisprecision medicine

Identifiers

PMID38860844
PMCPMC11618115

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.